PITX1 and colorectal carcinoma: Epidemiological studies have shown that the abundance of ETBF is significantly increased in patients with CRC.3,39 Animal model studies have also shown that ETBF can promote tumorigenesis by releasing B. fragilis toxin (BFT), a genotoxic compound.